Analytical Data
-
Gene name
P2
- Application
-
Alternative Names
Protein P2
-
Species
Pseudomonas phage phi6
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P11124
-
Expression Region
310-485aa
-
Molecular Weight
27.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
P2 recombinant proteins have garnered significant attention in the field of molecular biology and biotechnology due to their crucial roles in various biological processes and their applications in therapeutic development. The P2 protein, derived from specific pathogens or organisms, often serves as a model for studying protein structure, function, and interaction within cellular systems. Research into P2 recombinant proteins typically focuses on their expression, purification, and characterization, as well as their potential uses in vaccine development, where they can elicit immune responses without the risks associated with live pathogens. Additionally, P2 proteins are instrumental in understanding the mechanisms of diseases, thereby aiding in the discovery of novel drug targets. Advances in genetic engineering and recombinant DNA technology have facilitated the production of P2 proteins in host organisms, allowing for large-scale production and detailed studies. As a result, P2 recombinant protein research is pivotal in enhancing our understanding of biological systems and advancing medical interventions, particularly in combating infectious diseases and improving vaccine efficacy. The ongoing exploration of P2 proteins continues to promise innovations in therapeutic applications and diagnostic tools, marking them as an important focus in contemporary biomedical research.
